That's not the reason that treatments are not consistent between mice and humans, it's because mouse models are constructed to replicate the expression of single genes or symptoms and then to test for the efficacy of that single thing.Actually you can, you are not certain it will work, but many times it just does.
Treatments for androgenic alopecia have a hard time being consistent between mice and humans because this is a disease that just doesen't show in them.
However, Tsuji's research is about hair cloning, and not some treatment for Androgenetic Alopecia, so i think there's a higher chance that findings will be consistent.
Remember that if a molecule doesen't show efficacy, there's not much you can do, but with hair cloning they will be able to adjust and gradually find the optimal process.
When this translates to humans, that single thing might not be sufficient to reverse the condition alone or the targeting of that single thing might not be achievable without toxic or unintended downstream effects. Androgenic alopecia is a perfect example of why these things don't translate well because it's a very polygenic condition that can be targeted from multiple angles. All of the prior mouse models that "cured" baldness or regrew hair probably did so quite well when JUST the follicle or AR is targeted on the mouse, but the issue is that you can't target JUST the follicles on the human body without effecting things systematically and destroying other body systems. Otherwise you could just get the strongest topical AA possible and you'd basically have a cure, infact I think we already have examples of this in some of the strongest AAs on the market used for things like cancers. I'm sure one of the more experienced/knowledgeable posters here could quote you some very potent AAs that would essentially cure hair loss (not regrowth), but can't be used because they can't be used in doses needed without going systematic.
Last edited: